Teva DuoResp Spiromax inhalation powder

DuoResp Spiromax is a prescription pharmaceutical product used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a combination inhaler containing budesonide and formoterol. The medication is delivered via the Spiromax inhaler, an innovative multi-dose dry powder inhaler technology.

The product is part of the portfolio of Teva Pharmaceuticals, a global leader in generic and specialty medicines. While the brand has global reach, this specific medication is manufactured at Teva's production site in Waterford, Ireland, which is a key hub for respiratory products. Teva, originally founded in Israel in 1901, has grown into one of the world's largest pharmaceutical companies through strategic acquisitions and internal development.